This measures group is to be reported for re patients aged 18 year and older with a specific diagnosis of chronic hepatitis C accompanied by a specific patient encounter:
One of the following diagnosis codes indicating chronic hepatitis C:
ICD-9-CM [for use 1/1/2015 – 9/30/2015]: 070.54
ICD-10-CM [for use 10/1/2015 - 12/31/2015]: B18.2
One of the following patient encounter codes:
99201, 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 99349,99350, 99406, 9940
Measure #87 only needs to be reported if initiation of antiviral treatment took place before October of the measurement year (12 weeks before the end of the measurement period).
Measure #401 only needs to be reported when the patient also has the following diagnosis code indicating cirrhosis:
ICD-9-CM [for use 1/1/2015 – 9/30/2015]: 571.2, 571.5
ICD-10-CM [for use 10/1/2015 - 12/31/2015]: K70.30, K70.31, K74.60, K74.69
2015 PQRS MEASURES IN HEPATITIS C MEASURES GROUP:
#84 Hepatitis C: Ribonucleic Acid (RNA) Testing Before Initiating Treatment
#85 Hepatitis C: HCV Genotype Testing Prior to Treatment
#87 Hepatitis C: Hepatitis C Virus (HCV) Ribonucleic Acid (RNA) Testing Between 4-12 Weeks After Initiation of Treatment
#130 Documentation of Current Medications in the Medical Record
#183 Hepatitis C: Hepatitis A Vaccination
#226 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
#390 Discussion and Shared Decision Making Surrounding Treatment Options
#401 Screening for Hepatocellular Carcinoma (HCC) in Patients with Hepatitis C Cirrhosis
Register now with MDinteractive, report on all applicable measures described above for a minimum of 20 unique patients (11 of which must be Part B Fee-For-Service patients) and avoid the 4% penalty.
An answer of "Not Done" on all patients on one measure will result in a performance rate of 0% and the provider will NOT get the PQRS incentive.
Each provider needs to sign a PQRS consent at http://mdinteractive.com/webpen